The DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Involvement of Interferon-γ in Microglial-Mediated Loss of Dopaminergic Neurons
Open accessAbstract
Growing evidence implicates microglia in the loss of dopaminergic neurons in Parkinson's disease (PD). However, factors mediating microglial activation in PD are poorly understood. Proinflammatory cytokines, such as interferon-γ (IFN-γ), orchestrate the actions of microglia. We report here that PD patients express significantly elevated levels of IFN-γ in their blood plasma. After this initial finding, we found that IFN-γ-deficient mice displayed attenuated 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced substantia nigra pars compacta dopaminergic cell loss along with reduced loss of striatal tyrosine hydroxylase and dopamine transporter fiber density. MPTP-induced depletion of striatal dopamine and its metabolite DOPAC (3,4-dihydroxyphenylacetic acid), as well as ΔFosB, a marker of postsynaptic dysfunction, were also attenuated in these knock-out mice. Consistent with the role for IFN-γ in microglial activation, MPTP-induced morphological activation of microglia was abrogated compared with wild-type mice. To examine more mechanistically the role of IFN-γ in microglial activation, we evaluated the interactions between microglia and dopaminergic neurons in an in vitro mixed microglia/midbrain neuron rotenone-induced death paradigm. In this in vitro paradigm, dopaminergic neurons are selectively damaged by rotenone. Exogenous IFN-γ ligand alone and without rotenone resulted in dopaminergic cell loss, but only in the presence of microglia. The addition of an IFN-γ neutralizing antibody attenuated neuronal loss as a result of rotenone treatment. The presence of only wild-type microglia and not those deficient in IFN-γ receptor elicited significant dopaminergic cell loss when exposed to rotenone. Neurons deficient in IFN-γ receptor, however, did not display increased resistance to death. Finally, levels of IFN-γ message increased in microglia in response to rotenone. Together, these data suggest that IFN-γ participates in death of dopaminergic neurons by regulating microglial activity.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Mouse Brain in Stereotaxic Coordinates
Paxinos, G. (2001) · Cited by 13,416
McGeer, P. L., Itagaki, S., Boyes, B. E., & McGeer, E. G. (1988) · Neurology · doi:10.1212/wnl.38.8.1285 · Cited by 2,990
Gundersen, H. J. G., Bagger, P., Bendtsen, T. F., Evans, S. M., Korbo, L., Marcussen, N., MØLler, A., Nielsen, K., Nyengaard, J. R., Pakkenberg, B., et al. (1988) · APMIS · doi:10.1111/j.1699-0463.1988.tb00954.x · Cited by 2,478
Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183 · cited 3×
“The use of the pharmacological anti-inflammatory agent minocycline attenuates activation of microglia as well as MPTP-induced dopaminergic cell loss (Du et al., 2001; Wu et al., 2002).”
BackgroundLehnardt, S., Massillon, L., Follett, P., Jensen, F. E., Ratan, R., Rosenberg, P. A., Volpe, J. J., & Vartanian, T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1432609100 · Cited by 1,052
Chen, M., Ona, V. O., Li, M., Ferrante, R. J., Fink, K. B., Zhu, S., Bian, J., Guo, L., Farrell, L. A., Hersch, S. M., et al. (2000) · Nature Medicine · doi:10.1038/77528 · Cited by 1,051
Liberatore, G. T., Jackson-Lewis, V., Vukosavic, S., Mandir, A. S., Vila, M., McAuliffe, W. G., Dawson, V. L., Dawson, T. M., & Przedborski, S. (1999) · Nature Medicine · doi:10.1038/70978 · Cited by 1,046 · cited 2×
“This notion is supported by the fact that MPTP (MPP metabolite) can directly target mitochondria in neurons and lead to increased ROS and damage (Liberatore et al., 1999; Dehmer et al., 2000; Gonzalez-Polo et al., 2004; Chen et al., 2006).”
BackgroundMicroglial activation and dopamine terminal loss in early Parkinson's disease
Ouchi, Y., Yoshikawa, E., Sekine, Y., Futatsubashi, M., Kanno, T., Ogusu, T., & Torizuka, T. (2005) · Annals of Neurology · doi:10.1002/ana.20338 · Cited by 843
Du, Y., Ma, Z., Lin, S., Dodel, R. C., Gao, F., Bales, K. R., Triarhou, L. C., Chernet, E., Perry, K. W., Nelson, D. L. G., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251341998 · Cited by 789
Gao, H., Jiang, J., Wilson, B., Zhang, W., Hong, J., & Liu, B. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00928.x · Cited by 687
Wu, D.-C., Teismann, P., Tieu, K., Vila, M., Jackson-Lewis, V., Ischiropoulos, H., & Przedborski, S. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0937239100 · Cited by 633
Interferon regulatory factors: the next generation
Mamane, Y., Heylbroeck, C., Génin, P., Algarté, M., Servant, M. J., LePage, C., DeLuca, C., Kwon, H., Lin, R., & Hiscott, J. (1999) · Gene · doi:10.1016/s0378-1119(99)00262-0 · Cited by 562
Perry, V. H. (2004) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2004.01.004 · Cited by 560 · cited 1×
“However, systemic IFN- -producing inflammatory cells have been reported to infiltrate the brain (Perry, 2004).”
BackgroundBlood-brain barrier transport of cytokines: a mechanism for neuropathology
Banks, W. (2005) · Current Pharmaceutical Design · doi:10.2174/1381612053381684 · Cited by 534
Przedborski, S., Jackson‐Lewis, V., Naini, A. B., Jakowec, M., Petzinger, G., Miller, R., & Akram, M. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00183.x · Cited by 507
Inflammatory processes in amyotrophic lateral sclerosis
McGeer, P. L., & McGeer, E. G. (2002) · Muscle & Nerve · doi:10.1002/mus.10191 · Cited by 470 · cited 2×
“Indeed, microglial activation has been noted in PD animal models and postmortem brains (McGeer et al., 1988; Banati et al., 1998).”
BackgroundDistinct Role for Microglia in Rotenone-Induced Degeneration of Dopaminergic Neurons
Gao, H.-M., Hong, J.-S., Zhang, W., & Liu, B. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-03-00782.2002 · Cited by 439
Glial pathology but absence of apoptotic nigral neurons in long‐standing Parkinson's disease
Banati, R. B., Daniel, S. E., & Blunt, S. B. (1998) · Movement Disorders · doi:10.1002/mds.870130205 · Cited by 431
Hunot, S., Dugas, N., Faucheux, B., Hartmann, A., Tardieu, M., Debré, P., Agid, Y., Dugas, B., & Hirsch, E. C. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-09-03440.1999 · Cited by 408
The MPTP model of Parkinson's disease
Smeyne, R. J., & Jackson-Lewis, V. (2005) · Molecular Brain Research · doi:10.1016/j.molbrainres.2004.09.017 · Cited by 377
Butovsky, O., Talpalar, A. E., Ben-Yaakov, K., & Schwartz, M. (2005) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2005.03.005 · Cited by 365
Liu, B., Du, L., & Hong, J.-S. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39275-4 · Cited by 347 · cited 2×
“5) mice, as described previously (Liu et al., 2000).”
Deficiency of Inducible Nitric Oxide Synthase Protects Against MPTP Toxicity In Vivo
Dehmer, T., Lindenau, J., Haid, S., Dichgans, J., & Schulz, J. B. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0742213.x · Cited by 337
Smith, P. D., Crocker, S. J., Jackson-Lewis, V., Jordan-Sciutto, K. L., Hayley, S., Mount, M. P., O'Hare, M. J., Callaghan, S., Slack, R. S., Przedborski, S., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2232515100 · Cited by 319
Self-citationCytokines in Parkinson’s disease
Nagatsu, T., Mogi, M., Ichinose, H., & Togari, A. (2000) · Advances in Research on Neurodegeneration · doi:10.1007/978-3-7091-6284-2_12 · Cited by 308
Kostic, V., Przedborski, S., Flaster, E., & Sternic, N. (1991) · Neurology · doi:10.1212/wnl.41.2_part_1.202 · Cited by 297
Członkowska, A., Kohutnicka, M., Kurkowska-Jastrzębska, I., & Członkowski, A. (1996) · Neurodegeneration · doi:10.1006/neur.1996.0020 · Cited by 279
Crocker, S. J., Smith, P. D., Jackson-Lewis, V., Lamba, W. R., Hayley, S. P., Grimm, E., Callaghan, S. M., Slack, R. S., Melloni, E., Przedborski, S., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-10-04081.2003 · Cited by 274
Self-citationGao, H.-M., Hong, J.-S., Zhang, W., & Liu, B. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-04-01228.2003 · Cited by 251
Almer, G., Vukosavic, S., Romero, N., & Przedborski, S. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0722415.x · Cited by 231
Barcia, C., Bahillo, A. S., Fernández‐Villalba, E., Bautista, V., Poza Y Poza, M., Fernández‐Barreiro, A., Hirsch, E. C., & Herrero, M. (2004) · Glia · doi:10.1002/glia.20015 · Cited by 206
Zeng, H.-Y., Zhu, X.-A., Zhang, C., Yang, L.-P., Wu, L.-M., & Tso, M. O. M. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0118 · Cited by 203
So?tys, Z., Ziaja, M., Pawli?ski, R., Setkowicz, Z., & Janeczko, K. (2001) · Journal of Neuroscience Research · doi:10.1002/1097-4547(20010101)63:1<90::aid-jnr11>3.0.co;2-9 · Cited by 197
Moss, D. W., & Bates, T. E. (2001) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2001.01418.x · Cited by 192
Chen, J., Tang, X. Q., Zhi, J. L., Cui, Y., Yu, H. M., Tang, E. H., Sun, S. N., Feng, J. Q., & Chen, P. X. (2006) · Apoptosis · doi:10.1007/s10495-006-6715-5 · Cited by 184
Rymar, V. V., Sasseville, R., Luk, K. C., & Sadikot, A. F. (2004) · Journal of Comparative Neurology · doi:10.1002/cne.11008 · Cited by 174
Increased neopterin production and tryptophan degradation in advanced Parkinson's disease.
Widner, B., Leblhuber, F., & Fuchs, D. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200014 · Cited by 171
Abbas, N., Bednar, I., Mix, E., Marie, S., Paterson, D., Ljungberg, A., Morris, C., Winblad, B., Nordberg, A., & Zhu, J. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00050-4 · Cited by 161
Gao, H., Liu, B., Zhang, W., & Hong, J. (2003) · The FASEB Journal · doi:10.1096/fj.03-0203fje · Cited by 160
Minocycline Enhances MPTP Toxicity to Dopaminergic Neurons
Yang, L., Sugama, S., Chirichigno, J. W., Gregorio, J., Lorenzl, S., Shin, D. H., Browne, S. E., Shimizu, Y., Joh, T. H., Beal, M. F., et al. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10709 · Cited by 158 · cited 2×
“Moreover, others have reported that minocycline can exacerbate MPTPinduced toxicity (Yang et al., 2003).”
BackgroundXie, Z., Morgan, T. E., Rozovsky, I., & Finch, C. E. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00057-8 · Cited by 152
Li, F.-Q., Wang, T., Pei, Z., Liu, B., & Hong, J. (2004) · Journal of Neural Transmission · doi:10.1007/s00702-004-0213-0 · Cited by 147
Członkowska, A., Kurkowska‐Jastrzębska, I., Członkowski, A., Peter, D., & Stefano, G. B. (2002) · PubMed · Cited by 133
Roles of Glia‐Derived Cytokines on Neuronal Degeneration and Regeneration
Suzumura, A., Takeuchi, H., Zhang, G., Kuno, R., & Mizuno, T. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1366.012 · Cited by 130
Seegal, R. F., Brosch, K. O., & Bush, B. (1986) · Journal of Chromatography B Biomedical Sciences and Applications · doi:10.1016/s0378-4347(00)80768-9 · Cited by 128
Hayley, S. P., Crocker, S. J., Smith, P. D., Shree, T., Jackson-Lewis, V. R., Przedborski, S., Mount, M., Slack, R. S., Anisman, H., & Park, D. S. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.4564-03.2004 · Cited by 125
Self-citationArai, H., Furuya, T., Yasuda, T., Miura, M., Mizuno, Y., & Mochizuki, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m407328200 · Cited by 122 · cited 2×
“Direct administration of lipopolysaccharide (LPS) induces microgliosis and has been correlated with the loss of dopaminergic neurons in vivo (Arai et al., 2004; De Pablos et al., 2005).”
BackgroundDelgado, M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303199200 · Cited by 101
Optimization of multiplexed bead-based cytokine immunoassays for rat serum and brain tissue
Hulse, R. E., Kunkler, P. E., Fedynyshyn, J., & Kraig, R. P. (2004) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2003.12.023 · Cited by 101
Meissner, W. G., Prunier, C., Guilloteau, D., Chalon, S., Gross, C. E., & Bézard, E. (2003) · Molecular Neurobiology · doi:10.1385/mn:28:3:209 · Cited by 96
Badie, B., Schartner, J. M., Vorpahl, J., & Preston, K. F. (2000) · Experimental Neurology · doi:10.1006/exnr.1999.7345 · Cited by 94
Investigating levodopa-induced dyskinesias in the parkinsonian primate.
Langston, J. W., Quik, M., Petzinger, G. M., Jakowec, M. W., & Monte, D. A. D. (2000) · PubMed · Cited by 89
Wei, X., Zhao, L., Liu, J., Dodel, R. C., Farlow, M. R., & Du, Y. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2004.11.014 · Cited by 87
INTERFERON γ GENE EXPRESSION IN RAT CENTRAL NERVOUS SYSTEM GLIAL CELLS
Simone, R. D., Levi, G., & Aloisi, F. (1998) · Cytokine · doi:10.1006/cyto.1997.0314 · Cited by 83
Are cytokines possible mediators of cancer cachexia?
Noguchi, Y., Yoshikawa, T., Matsumoto, A., Svaninger, G., & Gelin, J. (1996) · Surgery today (Print) · doi:10.1007/bf00311551 · Cited by 73
Ciesielska, A., Joniec‐Maciejak, I., Przybyłkowski, A. M., Gromadzka, G., Iwona, Członkowska, A., & Członkowski, A. (2003) · Acta Neurobiologiae Experimentalis · doi:10.55782/ane-2003-1461 · Cited by 72
Mandel, S. A., Grünblatt, E., & Youdim, M. B. H. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6301-6_7 · Cited by 66
Protection against MPP+ neurotoxicity in cerebellar granule cells by antioxidants
González‐Polo, R. A., Soler, G., Rodríguez-Martín, A., Morán, J. M., & Fuentes, J. M. (2004) · Cell Biology International · doi:10.1016/j.cellbi.2004.03.005 · Cited by 62
MPP+ Analogs Acting on Mitochondria and Inducing Neuro-Degeneration
Kotake, Y., & Ohta, S. (2003) · Current Medicinal Chemistry · doi:10.2174/0929867033456558 · Cited by 58
Okuno, T., Nakatsuji, Y., Kumanogoh, A., Moriya, M., Ichinose, H., Sumi, H., Fujimura, H., Kikutani, H., & Sakoda, S. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20599 · Cited by 56
Investigation of genes coding for inflammatory components in Parkinson's disease
Håkansson, A. S., Westberg, L., Nilsson, S., Buervenich, S., Belin, A. C., Holmberg, B., Sydow, O., Olson, L., Johnels, B., Eriksson, E., et al. (2005) · Movement Disorders · doi:10.1002/mds.20378 · Cited by 53
Dopamine‐dependent neurotoxicity of lipopolysaccharide in substantia nigra
de Pablos, R. M., Herrera, A. J., Villarán, R. F., Cano, J., & Machado, A. (2004) · The FASEB Journal · doi:10.1096/fj.04-2153fje · Cited by 44
Lymphocyte infiltration in the injured brain: Role of proinflammatory cytokines
Raivich, G., Bohatschek, M., Werner, A., Jones, L. L., Galiano, M., Kloss, C. U. A., Zhu, X., Pfeffer, K., & Liu, Z. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10621 · Cited by 38
Fukuda, T. (2001) · Neuropathology · doi:10.1046/j.1440-1789.2001.00402.x · Cited by 35
Mizuta, I. (2001) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.71.6.818a · Cited by 32
Platten, M., Wick, W., Wischhusen, J., & Weller, M. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704373 · Cited by 26
Human T lymphotropic virus type I (HTLV-1) associated myelopathy acquired through a liver transplant
Zarranz, J. J., Rouco, I., Gómez-Esteban, J. C., & Corral, J. (2001) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.71.6.818 · Cited by 26
Gribova, I., Bb, G., Vv, P., & Morozov, S. (2003) · PubMed · Cited by 10
Cited by
Microglia: Active sensor and versatile effector cells in the normal and pathologic brain
Hanisch, U.-K., & Kettenmann, H. (2007) · Nature Neuroscience · doi:10.1038/nn1997 · Cited by 3,676
The JAK/STAT signaling pathway: from bench to clinic
Hu, X., li, J., Fu, M., Zhao, X., & Wang, W. (2021) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-021-00791-1 · Cited by 2,633
Neuroinflammation in Parkinson’s disease: A target for neuroprotection?
Hirsch, E. C., & Hunot, S. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70062-6 · Cited by 1,984
Inflammation and immune dysfunction in Parkinson disease
Tansey, M. G., Wallings, R. L., Houser, M. C., Herrick, M. K., Keating, C. E., & Joers, V. (2022) · Nature Reviews Immunology · doi:10.1038/s41577-022-00684-6 · Cited by 1,382
Brochard, V., Combadière, B., Prigent, A., Laouar, Y., Perrin, A., Beray-Berthat, V., Bonduelle, O., Alvarez-Fischer, D., Callebert, J., Launay, J.-M., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36470 · Cited by 1,172
Metadata
- Authors
- Mount, M. P., Lira, A., Grimes, D., Smith, P. D., Faucher, S., Slack, R., Anisman, H., Hayley, S., & Park, D. S.
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2007-03-21
- Volume
- 27
- Issue
- 12
- Pages
- 3328-3337
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- OpenAlex
- W2050731687
- Cited by
- 315
- References
- 68
- FWCI
- 8.63
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.